Showing 621 - 640 results of 2,945 for search '"hepatitis"', query time: 0.06s Refine Results
  1. 621
  2. 622
  3. 623

    Primary hepatic leiomyosarcoma masquerading as focal nodular hyperplasia of liver: A wolf in sheep’s clothing by Ranajoy Ghosh, Aniket Halder, Ranjit K. Nim, Sukanta Ray, Uttara Chatterjee

    Published 2024-12-01
    “…Primary hepatic leiomyosarcoma is a rare hepatic malignancy which requires exclusion of other primary site of origin. …”
    Get full text
    Article
  4. 624

    PPARα Is Required for PPARδ Action in Regulation of Body Weight and Hepatic Steatosis in Mice by Wojciech G. Garbacz, Jeffrey T. J. Huang, Larry G. Higgins, Walter Wahli, Colin N. A. Palmer

    Published 2015-01-01
    “…PPARδ (also known as PPARβ/δ) has been investigated as a promising antidiabetic drug target; however, the evidence in the literature on PPARδ effect on hepatic lipid metabolism is inconsistent. Mice conditionally expressing human PPARδ demonstrated pronounced weight loss and promoted hepatic steatosis when treated with GW501516 (PPARδ-agonist) when compared to wild type mice. …”
    Get full text
    Article
  5. 625
  6. 626

    Listeria monocytogenes Meningitis in an Immunosuppressed Patient with Autoimmune Hepatitis and IgG4 Subclass Deficiency by Shahin Gaini

    Published 2015-01-01
    “…Her medical history included immunosuppressive treatment with prednisolone and azathioprine for autoimmune hepatitis. A diagnostic work-up after the meningitis episode revealed that she had low levels of the IgG4 subclass. …”
    Get full text
    Article
  7. 627

    Intra-uterine Growth Restriction Downregulates the Hepatic Toll Like Receptor-4 Expression and Function by Ozlem Equils, Sapna Singh, Semra Karaburun, Daning Lu, Manikkavasagar Thamotharan, Sherin U. Devaskar

    Published 2005-01-01
    “…The hepatic TLR4 protein concentration was undetectable in the IUGR rats that had restricted milk intake during the suckling period (SM/SP; n = 4, p < 0.05) as compared to the normal growth controls (CM/CP; n=4), and access to ad lib milk intake during the sucking period partially corrected the hepatic TLR4 expression (SM/CP; n = 4). …”
    Get full text
    Article
  8. 628

    Successful Integration of Hepatitis C Virus Point-of-Care Tests into the Denver Metro Health Clinic by A. Jewett, A. A. Al-Tayyib, L. Ginnett, B. D. Smith

    Published 2013-01-01
    “…The Centers for Disease Control and Prevention (CDC) recommends testing and linkage to care for persons most likely infected with hepatitis C virus (HCV), including persons with human immunodeficiency virus. …”
    Get full text
    Article
  9. 629
  10. 630

    Empagliflozin Alleviates Hepatic Steatosis by Activating the AMPK-TET2-Autophagy Pathway in vivo and in vitro by Ting Li, Ting Fang, Linxin Xu, Xiangyang Liu, Xiaoyu Li, Mei Xue, Xiaochen Yu, Bei Sun, Liming Chen

    Published 2021-01-01
    “…Background: Metabolic associated fatty liver disease (MAFLD), characterized by hepatic lipid accumulation and fatty degeneration, is intertwined with obesity and type 2 diabetes mellitus (T2DM). …”
    Get full text
    Article
  11. 631
  12. 632

    Clinical Features of Adult Patients with Acute Hepatitis B Virus Infection Progressing to Chronic Infection by Kojiro Michitaka, Atsushi Hiraoka, Yoshio Tokumoto, Keiko Ninomiya, Tomoyuki Ninomiya, Norio Horiike, Masanori Abe, Yoichi Hiasa

    Published 2014-01-01
    “…Information regarding the progression of acute hepatitis B virus (HBV) infection to chronic infection in adults is scarce. …”
    Get full text
    Article
  13. 633

    Acute Sickle Hepatic Crisis after Liver Transplantation in a Patient with Hb SC Disease by J. H. Gillis, S. K. Satapathy, L. Parsa, P. B. Sylvestre, N. Dbouk

    Published 2015-01-01
    “…Acute sickle hepatic crisis (ASHC) has been observed in approximately 10% of patients with sickle cell disease. …”
    Get full text
    Article
  14. 634

    Mesenchymal Stem Cells Ameliorate Hepatic Ischemia/Reperfusion Injury via Inhibition of Neutrophil Recruitment by Shihui Li, Xu Zheng, Hui Li, Jun Zheng, Xiaolong Chen, Wei Liu, Yan Tai, Yingcai Zhang, Genshu Wang, Yang Yang

    Published 2018-01-01
    “…In the present study, we examined the impact of MSCs on hepatic inflammatory response such as neutrophil influx and liver damage in a rat model of 70% hepatic IRI. …”
    Get full text
    Article
  15. 635

    Canadian Hepatitis C Look-Back Investigation to Detect Transmission from an Infected General Surgeon by Meenakshi Dawar, Tammy L Stuart, Lamont E Sweet, Anne M Neatby, Lewis P Abbott, Anton P Andonov, Tom Wong, Robert Gervais, Rob Stirling

    Published 2010-01-01
    “…BACKGROUND: In February 2007, a general surgeon in Charlottetown, Prince Edward Island, tested positive for hepatitis C virus (HCV). The surgeon’s infection onset date could not be determined; however, episodic hepatic enzyme elevations were first detected in November 2004 and again in February 2007. …”
    Get full text
    Article
  16. 636

    Sofosbuvir-Based Therapies for Patients with Hepatitis C Virus Infection: Real-World Experience in China by Chengguang Hu, Guosheng Yuan, Junwei Liu, Huaping Huang, Yanyu Ren, Yinping Li, Xuefu Chen, Wei Li, Tao Wu, Hong Deng, Yanzhong Peng, Yong-Yuan Zhang, Yuanping Zhou

    Published 2018-01-01
    “…There is scarcity of data in literature regarding the treatment response to sofosbuvir- (SOF-) based therapies in Chinese patients with chronic Hepatitis C Virus (HCV) infection. The aim of this study was to evaluate the efficacy and safety of SOF-based regimens for chronic hepatitis C (CHC) patients without cirrhosis in a real-world setting in mainland China. …”
    Get full text
    Article
  17. 637
  18. 638

    Marijuana Use in Hepatitis C Infection does not Affect Liver Biopsy Histology or Treatment Outcomes by Theresa Liu, Glen T Howell, Lucy Turner, Kimberley Corace, Gary Garber, Curtis Cooper

    Published 2014-01-01
    “…BACKGROUND: Marijuana smoking is prevalent among hepatitis C virus-infected patients. The literature assessing the influence of marijuana on liver disease progression and hepatitis C virus antiviral treatment outcomes is conflicting.…”
    Get full text
    Article
  19. 639

    Activins and Follistatin in Chronic Hepatitis C and Its Treatment with Pegylated-Interferon-α Based Therapy by Bassem Refaat, Ahmed Mohamed Ashshi, Adel Galal El-Shemi, Esam Azhar

    Published 2015-01-01
    “…Pegylated-interferon-α based therapy for the treatment of chronic hepatitis C (CHC) is considered suboptimal as not all patients respond to the treatment and it is associated with several side effects that could lead to dose reduction and/or termination of therapy. …”
    Get full text
    Article
  20. 640

    Concurrent Hepatic Artery and Portal Vein Thrombosis after Orthotopic Liver Transplantation with Preserved Allografts by Arshad Khan, P. Park, Jose Oberholzer, Ivo Tzvetanov, Raquel Garcia Roca, Ron C. Gaba, Enrico Benedetti, Hoonbae Jeon

    Published 2014-01-01
    “…In fact, hepatopetal arterial and portal venous neovascularization are known albeit obscure phenomena that can preserve posttransplant hepatic function under the extenuating circumstances of complete interruption of blood flow to the graft. …”
    Get full text
    Article